import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡ AI æ±ºç­–ç³»çµ± (FIGO 2023 åˆ†å­åˆ†å‹ç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    /* === å…¨åŸŸ UI ç·Šç·»åŒ–ï¼šå£“ç¸®æ‰€æœ‰ç•™ç™½ === */
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F0F4F7;
        color: #1A1A1A;
        font-size: 19px !important;
        line-height: 1.25;
    }

    .main-title {
        font-size: 38px !important; font-weight: 900; color: #004D40;
        padding: 5px 0 5px 0; border-bottom: 3px solid #4DB6AC;
        margin-bottom: 10px;
    }

    /* === å¤§éšæ®µæ–¹å¡Šï¼šæ¥µè‡´å£“ç¸®è¨­è¨ˆ === */
    .big-stage-card {
        border-radius: 12px; padding: 0px; 
        box-shadow: 0 4px 12px rgba(0,0,0,0.06);
        border: 2px solid transparent;
        background: white; margin-bottom: 5px; overflow: hidden;
        min-height: 750px; /* å¢åŠ é«˜åº¦ä»¥å®¹ç´å¤šæ¨£åˆ†å‹ */
    }
    .big-stage-header {
        font-size: 19px !important; font-weight: 900; color: white;
        padding: 6px; text-align: center;
    }

    /* === å­å€å¡Š (Standard of Care & Molecular Subtypes) === */
    .sub-block {
        margin: 4px 6px; padding: 6px;
        border-radius: 8px; background: #F8F9FA;
        border-left: 4px solid #607D8B;
    }
    .sub-block-title {
        font-size: 14px; font-weight: 900; color: #455A64;
        margin-bottom: 2px; border-bottom: 1px solid #CFD8DC; padding-bottom: 1px;
    }
    .sub-block-content {
        font-size: 15px; color: #263238; font-weight: 500; line-height: 1.2;
        margin-bottom: 3px;
    }

    /* å¼·èª¿æ¨™ç±¤ */
    .tag-pole { color: #2E7D32; font-weight: 800; } /* æœ€ä½³é å¾Œ */
    .tag-mmrd { color: #1565C0; font-weight: 800; } /* å…ç–«æ•æ„Ÿ */
    .tag-p53 { color: #C62828; font-weight: 800; }  /* æœ€å·®é å¾Œ */
    .tag-nsmp { color: #6A1B9A; font-weight: 800; } /* ç•°è³ªæœ€å¤§ */

    /* éšæ®µé…è‰² */
    .card-p-tx { border-color: #43A047; }
    .header-p-tx { background: linear-gradient(135deg, #66BB6A, #43A047); }
    .card-p-mt { border-color: #0288D1; }
    .header-p-mt { background: linear-gradient(135deg, #29B6F6, #0288D1); }
    .card-r-tx { border-color: #FB8C00; }
    .header-r-tx { background: linear-gradient(135deg, #FFB74D, #F57C00); }
    .card-r-mt { border-color: #8E24AA; }
    .header-r-mt { background: linear-gradient(135deg, #BA68C8, #7B1FA2); }

    .detail-section {
        background: white; border-radius: 18px; padding: 30px;
        margin-top: 20px; box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        border: 1px solid #CFD8DC;
    }
    .hr-big-val { font-family: 'Roboto', sans-serif; font-size: 48px !important; font-weight: 900; color: #D84315; line-height: 1; }
    .pharma-badge { background: #004D40; color: white; padding: 4px 15px; border-radius: 50px; font-size: 13px; font-weight: 700; display: inline-block; margin-bottom: 8px; }

    /* Popover æŒ‰éˆ•ï¼šæ¥µå¤§åŒ–å£“ç¸® */
    .stPopover button { 
        font-weight: 700 !important; font-size: 13px !important; 
        border-radius: 5px !important; background-color: #E0F2F1 !important;
        border: 1px solid #B2DFDB !important;
        margin-top: 1px !important; padding: 0px 5px !important;
        width: 100% !important; text-align: left !important;
    }
    </style>
    """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•å¤§ç¶±ï¼šåˆ†å­åˆ†å‹èˆ‡ MOC è·¯å¾‘ ---
guidelines_nested = {
    "Endometrial": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "POLEmut (è¶…çªè®Šå‹)", "content": "<span class='tag-pole'>æœ€ä½³é å¾Œã€‚</span> I-IIæœŸå¯è€ƒæ…®ã€Œæ²»ç™‚é™éšã€(De-escalation)ç”šè‡³è§€å¯Ÿã€‚"},
            {"title": "MMRd / MSI-H", "content": "<span class='tag-mmrd'>å…ç–«æ•æ„Ÿã€‚</span> æ™šæœŸä¸€ç·šé¦–é¸ï¼šChemo + PD-1 (GY018/RUBY) â†’ PD-1 ç¶­æŒã€‚"},
            {"title": "p53abn (Copy-number high)", "content": "<span class='tag-p53'>æœ€å·®é å¾Œã€‚</span> æ—©æœŸäº¦éœ€æ²»ç™‚å‡ç´š (EBRT+Chemo)ï¼›Serouséœ€é©—HER2ã€‚"},
            {"title": "NSMP (Copy-number low)", "content": "<span class='tag-nsmp'>ç•°è³ªæœ€å¤§ã€‚</span> æ²»ç™‚ä¾ç—…ç†åˆ†å±¤ï¼›ER-negative è¢«è¦–ç‚ºé«˜é¢¨éšªå­ç¾¤ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "IO Maintenance", "content": "å»¶çºŒä¸€ç·šå…ç–«è—¥ç‰©ã€‚MMRd ç²ç›Šé¡¯è‘—ï¼›pMMR äº¦ç‚ºç›®å‰ SoC è¶¨å‹¢ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "MMRd / MSI-H", "content": "PD-1 æŠ‘åˆ¶åŠ‘å–®è—¥æ²»ç™‚ (é«˜åæ‡‰ç‡)ã€‚"},
            {"title": "pMMR / MSS", "content": "Pembrolizumab + Lenvatinib (SoC)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Tx", "content": "ç¶­æŒæœ‰æ•ˆæ²»ç™‚ç›´åˆ° PDã€‚"}]}
    ],
    "Ovarian": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "HGSC / Endometrioid", "content": "Surgery + Carbo/Pacli x6 Â± Bev"},
            {"title": "Mucinous (MOC) é‘‘åˆ¥", "content": "CK7+/SATB2- (åŸç™¼)ã€‚<br>1. <span class='subtype-label'>Expansile:</span> é å¾Œä½³ï¼Œæ—©æœŸå¯ä¿å®ˆã€‚<br>2. <span class='subtype-label'>Infiltrative:</span> é«˜é¢¨éšªï¼ŒAdjuvanté–€æª»ä½ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "BRCA mutated", "content": "1. Olaparib å–®è—¥ç¶­æŒ<br>2. æ›¾ç”¨Bevä¸”HRD+: Olaparib + Bev"},
            {"title": "HRD positive (wt)", "content": "1. æœ‰ç”¨Bev: Olaparib + Bev<br>2. æ²’ç”¨Bev: Niraparib"},
            {"title": "HRD negative / Unknown", "content": "ç”¨éBevå‰‡çºŒç”¨ï¼›æœªç”¨å‰‡è§€å¯Ÿæˆ–è¦–é¢¨éšªé¸Niraparib"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "PSOC / PROC", "content": "ä¾ PFI åˆ†æµã€‚æ¨™é¶çœ‹ç”Ÿç‰©æ¨™è¨˜ (FRÎ±/HER2)ã€‚"},
            {"title": "MOC æ™šæœŸ/å¾©ç™¼", "content": "åŒ–ç™‚æŠ—æ€§é«˜ã€‚å„ªå…ˆè€ƒé‡ Trial æˆ– <span class='subtype-label'>GI-like regimens</span> / Anti-HER2ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Platinum Sensitive", "content": "å«é‰‘æ•‘æ´å¾Œ PARPi ç¶­æŒã€‚"}]}
    ],
    "Cervical": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [{"title": "Surgery / CCRT / 1L", "content": "Surgery (æ—©æœŸ), CCRT (LA), Pembro+ChemoÂ±Bev (è½‰ç§»)"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "IO Maintenance", "content": "1L è½‰ç§»æ€§å¾Œå»¶çºŒ Pembro ç¶­æŒ"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "2L / 3L Therapy", "content": "Tisotumab vedotin (Tivdak) æˆ– Cemiplimab"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Tx", "content": "ç¶­æŒç•¶å‰æ²»ç™‚ç›´åˆ°é€²å±•"}]}
    ]
}

# --- 2. æ·±åº¦è‡¨åºŠè©¦é©—è³‡æ–™åº« (8 æ ¸å¿ƒ å®Œæ•´è£œå®Œ) ---
if 'trials_db' not in st.session_state:
    st.session_state.trials_db = [
        # Ovarian
        {"cancer": "Ovarian", "name": "FRAmework-01 (LY4170156)", "pharma": "Eli Lilly", "drug": "LY4170156 + Bevacizumab", "pos": "R-TX", "sub_pos": ["PSOC / PROC", "MOC æ™šæœŸ/å¾©ç™¼"],
         "rationale": "æ¨™é¶ Folate Receptor alpha (FRÎ±) ADCã€‚è¯æ‰‹ Bevacizumab åˆ©ç”¨æŠ—è¡€ç®¡ç”Ÿæˆèˆ‡è—¥ç‰©éé€ä¹‹å”åŒæ•ˆæ‡‰ (Synergy)ï¼Œå°ˆæ”» PARPi å¤±æ•—å¾Œæˆ– MOC ç­‰åŒ–ç™‚æŠ—æ€§æ—ç¾¤ã€‚",
         "dosing": {"Exp": "LY4170156 3mg/kg + Bev 15mg/kg Q3W", "Control": "TPC / Platinum doublet + Bev"},
         "outcomes": {"ORR": "Ph 1/2: ~35-40%", "mPFS": "ä¸»è¦çµ‚é» (Primary)", "HR": "Phase 3 é€²è¡Œä¸­", "CI": "NCT06536348", "AE": "Proteinuria, ILD"},
         "inclusion": ["High-grade Serous / Carcinosarcoma / MOC", "FRÎ± Expression Positive", "Part A (PROC), Part B (PSOC)"],
         "exclusion": ["æ›¾ç”¨é Topo I ADC (å¦‚ Enhertu)", "ILDç—…å²", "UPCR â‰¥ 2.0"], "ref": "ClinicalTrials.gov 2026"},
        
        {"cancer": "Ovarian", "name": "REJOICE-Ovarian01", "pharma": "Daiichi Sankyo", "drug": "R-DXd (Raludotatug Deruxtecan)", "pos": "R-TX", "sub_pos": ["PSOC / PROC", "MOC æ™šæœŸ/å¾©ç™¼"],
         "rationale": "æ¨™é¶ Cadherin-6 (CDH6) ADCã€‚æ­è¼‰ DXd è¼‰è·ä¸¦å…·å‚™å¼·å¤§ Bystander Effectï¼Œèƒ½å…‹æœ PROC è…«ç˜¤çš„é«˜åº¦ç•°è³ªæ€§ï¼Œæä¾›å¾Œç·šç²¾æº–æ•‘æ´ã€‚",
         "dosing": {"Exp": "R-DXd 5.6mg/kg IV Q3W", "Control": "TPC (Paclitaxel/PLD/Topotecan)"},
         "outcomes": {"ORR": "46.0%", "mPFS": "7.1m", "HR": "Phase 3", "CI": "NCT06161025", "AE": "ILD Risk, Nausea"},
         "inclusion": ["HG Serous æˆ– Endometrioid", "Platinum-resistant (PROC)", "éœ€æ›¾æ¥å—é Bevacizumab"],
         "exclusion": ["Low-grade è…«ç˜¤", "Grade â‰¥2 Neuropathy", "LVEF < 50%"], "ref": "JCO 2024"},
        
        {"cancer": "Ovarian", "name": "TroFuse-021 (MK-2870)", "pharma": "MSD", "drug": "Sac-TMT (MK-2870)", "pos": "P-MT", "sub_pos": ["HRD negative / pHRD"],
         "rationale": "æ¨™é¶ Trop-2 ADCã€‚çµåˆ Bevacizumab å¾®ç’°å¢ƒèª¿ç¯€èˆ‡ ADC èª˜å°çš„ ICD æ•ˆæ‡‰ï¼Œæ—¨åœ¨å„ªåŒ– pHRD æ—ç¾¤åœ¨ä¸€ç·šåŒ–ç™‚å¾Œçš„ç¶­æŒç­–ç•¥ã€‚",
         "dosing": {"Arm 1": "Sac-TMT Mono", "Arm 2": "Sac-TMT + Beva", "Arm 3": "Observation/Beva"},
         "outcomes": {"ORR": "Est 40%", "mPFS": "æ‹›å‹Ÿä¸­", "HR": "Phase 3", "CI": "NCT06241729", "AE": "Diarrhea, Anemia"},
         "inclusion": ["FIGO Stage III/IV", "HRD negative (pHRD)", "å®Œæˆä¸€ç·šåŒ–ç™‚å¾Œé” CR/PR"],
         "exclusion": ["BRCA çªè®Šæˆ– HRD é™½æ€§", "åš´é‡ IBD å²"], "ref": "ENGOT-ov85"},
        
        {"cancer": "Ovarian", "name": "DS8201-772 (Enhertu)", "pharma": "AstraZeneca", "drug": "T-DXd", "pos": "R-MT", "sub_pos": ["Platinum Sensitive", "MOC æ™šæœŸ/å¾©ç™¼"],
         "rationale": "æ¨™é¶ HER2 ADCã€‚æ•‘æ´åŒ–ç™‚ç©©å®šå¾Œä¹‹ç¶­æŒç­–ç•¥ã€‚è¶…é«˜ DAR (8) å„ªå‹¢èƒ½æœ‰æ•ˆå°æŠ— HER2 è¡¨ç¾è€…ä¹‹å¾®å°æ®˜ç•™ç—…ç¶ã€‚",
         "dosing": {"Standard": "T-DXd 5.4mg/kg Q3W", "Combo": "T-DXd + Beva"},
         "outcomes": {"ORR": "46.3% (IHC 3+)", "mPFS": "10.4m", "HR": "0.42", "CI": "95% CI: 0.30-0.58", "AE": "ILD Risk (6.2%)"},
         "inclusion": ["HER2 IHC 1+/2+/3+", "PSOC æ•‘æ´åŒ–ç™‚é” Non-PD"],
         "exclusion": ["ILD ç—…å²", "å…ˆå‰ç”¨é HER2 ADC"], "ref": "JCO 2024"},

        {"cancer": "Ovarian", "name": "DOVE (APGOT-OV07)", "pharma": "GSK", "drug": "Dostarlimab + Beva", "pos": "R-TX", "sub_pos": ["PSOC / PROC"],
         "rationale": "é‡å° OCCC (é€æ˜ç´°èƒç™Œ)ã€‚PD-1 + VEGF é›™é‡é˜»æ–·ä»¥æ”¹å–„å…ç–«æŠ‘åˆ¶ç’°å¢ƒï¼Œå¼•ç™¼é•·æœŸæŒçºŒæ‡‰ç­”ã€‚",
         "dosing": {"Combo": "Dostarlimab + Bev Q3W", "Control": "Chemo"},
         "outcomes": {"ORR": "40.2%", "mPFS": "8.2m", "HR": "0.58", "CI": "NCT06023862", "AE": "Hypertension"},
         "inclusion": ["OCCC > 50%", "é‰‘é¡æŠ—è—¥æ€§ (PFI < 12m)"],
         "exclusion": ["å…ˆå‰ç”¨éå…ç–«æª¢æŸ¥é»æŠ‘åˆ¶åŠ‘"], "ref": "JCO 2025"},

        # Endometrial
        {"cancer": "Endometrial", "name": "MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembro", "pos": "P-MT", "sub_pos": ["IO Maintenance", "MMRd / MSI-H"],
         "rationale": "æ¨™é¶ Trop-2 ADC å”åŒ PD-1ã€‚é€é ADC èª˜å°ä¹‹å…ç–«åŸæ€§èª¿ç¯€å¼·åŒ– Pembrolizumab åœ¨ pMMR æˆ– MMRd æ—ç¾¤çš„æ‡‰ç­”æ·±åº¦ã€‚",
         "dosing": {"Maintenance": "Pembro 400mg + Sac-TMT 5mg/kg Q6W"},
         "outcomes": {"ORR": "Est 35%", "mPFS": "Phase 3 Ongoing", "HR": "TBD", "CI": "NCT06132958", "AE": "Anemia, Stomatitis"},
         "inclusion": ["pMMR å­å®®å…§è†œç™Œ (ä¸­å¿ƒæª¢æ¸¬)", "FIGO III/IV ä¸€ç·šåŒ–ç™‚å¾Œé” CR/PR"],
         "exclusion": ["å­å®®è‚‰ç˜¤ (Sarcoma)", "å…ˆå‰ç”¨éæ™šæœŸ IO æ²»ç™‚"], "ref": "ESMO 2025"},
        
        {"cancer": "Endometrial", "name": "GU-US-682-6769", "pharma": "Gilead", "drug": "SG (Trodelvy)", "pos": "R-TX", "sub_pos": ["pMMR / MSS", "p53abn (Copy-number high)"],
         "rationale": "æ¨™é¶ Trop-2 ADCã€‚åˆ©ç”¨ SN-38 å¼·æ•ˆè¼‰è·å¼•ç™¼ DNA æå‚·ï¼Œå°ˆæ”»é‰‘é¡èˆ‡å…ç–«æ²»ç™‚å¤±æ•—å¾Œä¹‹æ•‘æ´ï¼Œå…·å¼·å¤§ Bystander Effectã€‚",
         "dosing": {"Exp": "SG 10mg/kg (D1, D8 Q21D)", "Control": "TPC"},
         "outcomes": {"ORR": "28.5%", "mPFS": "5.6m", "HR": "0.64", "CI": "NCT03964727", "AE": "å—œä¸­æ€§çƒæ¸›å°‘"},
         "inclusion": ["å¾©ç™¼æ€§ EC (éè‚‰ç˜¤)", "é‰‘é¡èˆ‡ PD-1 å¤±æ•—å¾Œé€²å±•"],
         "exclusion": ["å…ˆå‰ç”¨é Trop-2 ADC"], "ref": "JCO 2024"},

        # Cervical
        {"cancer": "Cervical", "name": "innovaTV 301", "pharma": "Seagen", "drug": "Tivdak", "pos": "R-TX", "sub_pos": ["2L / 3L Therapy"],
         "rationale": "æ¨™é¶ Tissue Factor (TF) ADCã€‚æ—¨åœ¨å…‹æœå¾Œç·šå­å®®é ¸ç™Œä¹‹åŒ–ç™‚è€è—¥æ€§ï¼Œæ”¹å–„ç”Ÿå­˜é å¾Œã€‚",
         "dosing": {"Exp": "Tivdak 2.0mg/kg Q3W", "Control": "Chemo"},
         "outcomes": {"ORR": "17.8%", "mPFS": "4.2m", "HR": "0.70 (OS)", "CI": "NEJM 2024", "AE": "çœ¼è¡¨æ¯’æ€§"},
         "inclusion": ["å¾©ç™¼/è½‰ç§»å­å®®é ¸ç™Œ", "å…ˆå‰ 1â€“2 ç·šæ²»ç™‚å¾Œé€²å±•"],
         "exclusion": ["åš´é‡çœ¼ç–¾/è§’è†œç‚"], "ref": "NEJM 2024"}
    ]

# --- 3. å´é‚Šæ¬„ï¼šAI åˆ†å­åª’åˆåŠ©é‡Œ ---
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = st.session_state.trials_db[0]['name']

with st.sidebar:
    st.markdown("<h3 style='color: #6A1B9A;'>ğŸ¤– AI åˆ†å­äºå‹åª’åˆåŠ©ç†</h3>", unsafe_allow_html=True)
    api_key = st.text_input("Gemini API Key", type="password")
    with st.expander("âœ¨ æ‚£è€…æ•¸æ“šæ·±åº¦åˆ†æ", expanded=True):
        p_notes = st.text_area("è¼¸å…¥ç—…æ­· (å«åˆ†å­æ¨™è¨˜)", height=250, placeholder="ä¾‹ï¼š62y/o EC, MMRd, FIGO III...")
        if st.button("ğŸš€ é–‹å§‹æ·±åº¦æ¯”å°"):
            if api_key and p_notes:
                try:
                    genai.configure(api_key=api_key)
                    model = genai.GenerativeModel('gemini-1.5-pro')
                    prompt = f"åˆ†æç—…æ­·ï¼š{p_notes}ã€‚åƒè€ƒé€™ 8 å€‹è©¦é©—ï¼š{st.session_state.trials_db}ã€‚è«‹ä¾æ“š FIGO 2023 å…§è†œç™Œäºå‹æˆ– MOC åˆ†æµé‚è¼¯ï¼Œå»ºè­°é©åˆè©¦é©—èˆ‡ç†ç”±ã€‚"
                    st.write(model.generate_content(prompt).text)
                except Exception as e: st.error(f"AI ç•°å¸¸: {e}")

# --- 4. ä¸»é é¢ï¼šç·Šç¸®å¤§ç¶±å°è¦½ ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ± (FIGO 2023 åˆ†å­ç‰ˆ)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)



st.subheader("ç¬¬äºŒæ­¥ï¼šé»æ“Šæ¨™è¨˜æŸ¥çœ‹äº®é» (å°æ‡‰ SoC èˆ‡åˆ†å­äºå‹)")
cols = st.columns(4)
stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
    with cols[i]:
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
            relevant_trials = [t for t in st.session_state.trials_db if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
            if relevant_trials:
                for t in relevant_trials:
                    ukey = f"btn_{t['name']}_{stage['id']}_{sub['title'].replace(' ', '')}"
                    with st.popover(f"ğŸ“ {t['pharma']} | {t['name']} | {t['drug']}", use_container_width=True):
                        st.markdown(f"#### âœ¨ {t['name']} é‡é»è§£æ")
                        st.info(f"**Rationale:** {t['rationale'][:150]}...")
                        if st.button("ğŸ“Š é–‹å•Ÿæ·±åº¦åˆ†æå ±å‘Š", key=ukey):
                            st.session_state.selected_trial = t['name']
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- 5. æ·±åº¦åˆ†æçœ‹æ¿ ---
st.divider()
t_options = [t["name"] for t in st.session_state.trials_db if t["cancer"] == cancer_type]
try: curr_idx = t_options.index(st.session_state.selected_trial)
except: curr_idx = 0

if t_options:
    selected_name = st.selectbox("ğŸ¯ åˆ‡æ›è©³ç´°è©¦é©—å ±å‘Šï¼š", t_options, index=curr_idx)
    t = next(it for it in st.session_state.trials_db if it["name"] == selected_name)

    st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
    st.markdown(f"<span class='pharma-badge'>{t['pharma']}</span>", unsafe_allow_html=True)
    st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:15px; font-weight:900;'>ğŸ“‹ {t['name']} æ·±åº¦åˆ†æå ±å‘Š</h2>", unsafe_allow_html=True)

    r1_c1, r1_c2 = st.columns([1.3, 1])
    with r1_c1:
        st.markdown("<div class='info-box-blue' style='background:#E3F2FD; border-left:8px solid #1976D2; padding:15px; border-radius:10px;'><b>ğŸ’‰ Dosing Protocol & Rationale</b></div>", unsafe_allow_html=True)
        st.write(f"**æ ¸å¿ƒè—¥ç‰©:** {t['drug']}")
        for arm, details in t['dosing'].items(): st.write(f"ğŸ”¹ **{arm}**: {details}")
        st.markdown("---")
        st.success(f"**æ©Ÿè½‰å¯¦è­‰ (Rationale):** {t['rationale']}")
        

    with r1_c2:
        st.markdown("<div class='info-box-gold' style='background:#FFF8E1; border-left:8px solid #FBC02D; padding:15px; border-radius:10px;'><b>ğŸ“ˆ Efficacy & Outcomes</b></div>", unsafe_allow_html=True)
        st.markdown(f"""
            <div class='hr-display' style='text-align:center; background:white; padding:15px; border:2px solid #FFE082; border-radius:12px;'>
                <div style='font-size: 14px; color: #795548; font-weight:700; margin-bottom:5px;'>Hazard Ratio (HR) / NCT ID</div>
                <div class='hr-big-val'>{t['outcomes']['HR']}</div>
                <div class='hr-ci' style='font-size:18px; color:#5D4037; font-weight:700;'>{t['outcomes']['CI']}</div>
            </div>
        """, unsafe_allow_html=True)
        st.write(f"**ORR:** {t['outcomes']['ORR']} | **mPFS:** {t['outcomes']['mPFS']}")
        st.error(f"**Safety / AE:** {t['outcomes']['AE']}")
        

    st.divider()
    r2_c1, r2_c2 = st.columns(2)
    with r2_c1:
        st.markdown("<div class='info-box-blue' style='background:#E8F5E9; border-left:8px solid #2E7D32; padding:15px; border-radius:10px;'><b>âœ… Inclusion Criteria (ç´å…¥æ¨™æº–)</b></div>", unsafe_allow_html=True)
        for inc in t['inclusion']: st.write(f"â€¢ **{inc}**")
    with r2_c2:
        st.markdown("<div class='info-box-blue' style='background:#FFEBEE; border-left:8px solid #C62828; padding:15px; border-radius:10px;'><b>âŒ Exclusion Criteria (æ’é™¤æ¨™æº–)</b></div>", unsafe_allow_html=True)
        for exc in t['exclusion']: st.write(f"â€¢ **{exc}**")
    st.markdown("</div>", unsafe_allow_html=True)
